Top View
- Position Statement on the Use of Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Virus Infection in Africa
- 7 Management of Hepatitis B and HIV Coinfection Clinical Protocol for the WHO European Region (2011 Revision)
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver D
- Repurposing of FDA Approved Drugs
- A Rapid and Sensitive UPLC-MS/MS Method for the Determination of Adefovir in Human Plasma: Application to a Pharmacokinetic Study
- Drug Discovery of Nucleos(T)Ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80Th Birthday
- Short‑Term Efficacy After Switching from Adefovir Dipivoxil and Tenofovir Disoproxil Fumarate Therapy to Tenofovir Alaferamide for Chronic Hepatitis B
- Adefovir Dipivoxil and Peginterferon Alfa-2A for the Treatment of Chronic Hepatitis B
- Adefovir (Hepsera®)
- ANTIRETROVIRAL CONTRAINDICATIONS and DRUG INTERACTIONS (Part of 5)
- Evaluation of Carcinogenicity Studies of Medicinal Products for Human Use Authorised Via the European Centralised Procedure
- Antiretroviral Therapy and Medical Management of Pediatric HIV Infection
- Hepsera) Reference Number: CP.PHAR.142 Effective Date: 08.28.18 Last Review Date: 11.20 Line of Business: HIM, Medicaid Revision Log
- Annex I Summary of Product Characteristics
- Medication Guidelines for Solid Organ Transplants
- Antiviral Treatment for Chronic Hepatitis B Virus Infection – Immune Modulation Or Viral Suppression?
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- CLDT600A2306 RAP Module 3
- Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
- Praa-ADEFOVIR
- Tutorial Article Use of Antiviral Medications Against Equine Herpes Virus Associated Disorders D
- SARS-Cov-2 Rdrp Inhibitors Selected from a Cell-Based SARS-Cov-2 Rdrp Activity Assay System
- List of Selected Drugs
- Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for Chronic Hepatitis B
- Vemlidy, INN-Tenofovir Alafenamide
- Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
- Biktarvy, INN-Bictegravir / Emtricitabine / Tenofovir Alafenamide
- NATIONAL INSTITUTE for HEALTH and CLINICAL EXCELLENCE Final Appraisal Determination Adefovir Dipivoxil and Peginterferon Alfa-2A
- Adefovir Dipivoxil) Tablets, for Oral Use Tablets: 10 Mg (3) Initial U.S
- The Anti–Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus
- Cidofovir Activity Against Poxvirus Infections
- Hepsera, INN-Adefovir Dipivoxil
- Peginterferon Alfa-2A (Pegasys®) EOCCO POLICY
- Supplementary Materials: a Meta-Analysis of the Efficacy of Interferon Mono-Therapy Or Combined with Different Nucleos(T)Ide Analogues for Chronic Hepatitis B
- Hbsag Seroclearance Or Seroconversion Induced by Peg-Interferon Alpha and Lamivudine Or Adefovir Combination Therapy in Chronic
- Susceptibility of Lamivudine-Resistant Hepatitis B Virus to Other Reverse Transcriptase Inhibitors
- Resolution Ap (2000) 1
- ARPEC Protocol for Drug Utilization Study
- Application for Inclusion of Tenofovir Alafenamide (Vemlidy®) Tablets on the WHO Model List of Essential Medicines
- Peginterferon Plus Adefovir Versus Either Drug Alone for Hepatitis Delta
- Summary of Key ARV Drug Interactions